Zhejiang Sigma Pharma

Zhejiang Sigma Pharma is a pharmaceutical company based in Quzhou, China, dedicated to the development and large-scale production of active pharmaceutical ingredients (APIs) and finished drug products. The company's portfolio primarily features small molecule therapeutics targeting cardiovascular conditions, gastrointestinal disorders, and infectious diseases. Operating with GMP-certified facilities, Zhejiang Sigma Pharma functions as both a proprietary drug manufacturer and a contract manufacturing partner for global markets. Their business model integrates R&D with high-volume chemical synthesis to provide cost-effective healthcare solutions. The company maintains a strong focus on international quality standards to facilitate exports to regulated markets, with key products including widely used generics such as statins and proton pump inhibitors.